retatrutide dosing clinical trials Phase III study demonstrates 30% weight loss retatrutide dose study trial doses

On tolerability, retatrutide's GI adverse event rate is higher than tirzepatide's at matched mechanistic dose, which is the tradeoff for the additional mechanism

Over the course of several weeks, as you continue with your treatment, these effects become more pronounced, helping you feel fuller for longer periods and reducing overall calorie consumption

Both formulations are administered as once-weekly SC injections due to the long half-life of Semaglutide (approximately one week)

When youre on GLP-1 medications, small, often unnoticed dietary habits like hidden calories and nutritional gaps can sneak in and stall your progress

Obesity Medicine